TT人甲状腺导管癌细胝�/title> - �뵺�羺�ٷ��ַ

细胞培养� >> 细胞�

TT人甲状腺导管癌细胝�/div>

产品介绍

目录叶�br/>Serial	TCHu 78
标识�?br/>Identifier	CSTR:19375.09.3101HUMTCHu78
描述 Description	TT细胞�?7岁女性甲状腺髓质癌患者的穿刺活检样本中建立� TT细胞持续产生高水平的降血钙素和CEA� 在更换培养基�?4小时�?2小时在培养基中检测到的免疫活性的降血钙素浓度分别�?900 pg/百万细胞�?700 pg/百万细胞� 72小时后CEA积累浓度超过27 ng/百万细胞� 在本库通过支原体检测、�br/>在本库通过STR检测、�/span>
动物种别 Organism	亹�/span>
性别 Gender	奲�/span>
组织来源 Tissue and Cell Type	甲状腺；髓质；癌
形�?br/>Morphology	上皮细胞
培养基和添加剁�br/>Complete Growth Medium and Culture Conditions	F-12K Nutrient Mixture (gibco by life technologies 21127-022)�?0%；优质胎牛血清，10%、�br/>气相：空气，95%；二氧化碳，5%、�br/>温度�?7摄氏度、�/span>
供应限制 Permits and Restrictions	A。仅供研究之用、�/span>
REFERENCE	Robbins , et al, editors. Advances in thyroid neoplasia, 1981. Rome: Field Educational Italia; 1981, pp. 95-105. Behr TM , et al. Improved treatment of medullary thyroid cancer in a nude mouse model by combined radioimmunochemotherapy: doxorubicin potentiates the therapeutic efficacy of radiolabeled antibodies in a radioresistant tumor type. Cancer Res. 57: 5309-5319, 1997. PubMed: 9393755